Paratek Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of therapies based upon tetracycline chemistry, has opened its expanded office in King of Prussia, PA. Located on First Avenue, the new space is designed to accommodate the company’s growing development, manufacturing, and commercial organizations. “It’s an incredibly exciting time at Paratek as we get closer to potentially bringing our lead product candidate, omadacycline, to market,” said E...